Artificial intelligence and breast screening: French Radiology Community position paper - 25/09/19
, C. Balleyguier c, L. Ceugnart d, P. Heid e, G. Lenczner f, A. Maire g, B. Séradour d, L. Verzaux e, P. Taourel cand
Conseil national professionnel de la radiologie et imagerie médicale (G4)
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
The objective of this article was to evaluate the evidence currently available about the clinical value of artificial intelligence (AI) in breast imaging. Nine experts from the disciplines involved in breast disease management – including physicists and radiologists – convened a meeting on June 3, 2019 to discuss the evidence for the use of this technology in plenary and focused sessions. Prior to the meeting, the group performed a literature review on predefined topics. This paper presents the consensus reached by this working group on recommendations for the future use of AI in breast screening and related research topics.
El texto completo de este artículo está disponible en PDF.Keywords : Artificial intelligence, Breast cancer, Screening program, Digital breast tomosynthesis, Digital mammography
Abbreviations : AI, MG, MLO, CC, CAD, ANN, CNN, Synth2DMG, QC, DL, R2, FDA, DBT, AP-HP
Esquema
Vol 100 - N° 10
P. 553-566 - octobre 2019 Regresar al número
Artículo precedente
- Breast tomosynthesis: What do we know and where do we stand?
- C. Mandoul, C. Verheyden, I. Millet, C. Orliac, E. Pages, I. Thomassin, P. Taourel
- Breast sonoelastography: Now and in the future
- B. Mesurolle, M. El Khoury, F. Chammings, M. Zhang, S. Sun
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.